Surgical Treatments for Multiple Primary Adenocarcinoma of the Lung Masao Nakata, MD, Shigeki Sawada, MD, Motohiro Yamashita, MD, Hideyuki Saeki, MD, Akira Kurita, MD, Shigemitsu Takashima, MD, Kazuo Tanemoto, MD The Annals of Thoracic Surgery Volume 78, Issue 4, Pages 1194-1199 (October 2004) DOI: 10.1016/j.athoracsur.2004.03.102
Fig 1 Pure ground-glass opacity that consisted of almost 100% homogeneous translucent density. The Annals of Thoracic Surgery 2004 78, 1194-1199DOI: (10.1016/j.athoracsur.2004.03.102)
Fig 2 Mixed ground-glass opacity (GGO) that consisted of GGO for more than 50% of the lesion. The Annals of Thoracic Surgery 2004 78, 1194-1199DOI: (10.1016/j.athoracsur.2004.03.102)
Fig 3 Solid lesion that consisted of ground-glass opacity for less than 50% of the lesion. The Annals of Thoracic Surgery 2004 78, 1194-1199DOI: (10.1016/j.athoracsur.2004.03.102)
Fig 4 Survival curves for patients with primary multiple adenocarcinomas. The 3-year overall survival rate was 92.9% and the 3-year disease-free survival rate was 81.1%. The Annals of Thoracic Surgery 2004 78, 1194-1199DOI: (10.1016/j.athoracsur.2004.03.102)